Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

New treatment methods are expected to be created for ALS patients. Amylyx submitted NDA of AMX0035 in the United States

PharmaSources/YiDecember 02, 2021

Tag: AMX0035 , ALS treatments , NDA